| 000 | 05557nam a2200457 c 4500 | ||
|---|---|---|---|
| 710 | 2 |
_aSpringerLink (Online service) _9106996 |
|
| 999 |
_c117891 _d117891 _x1 |
||
| 001 | 117891 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102113832.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 191106s2019 si a o |||| 0|eng d | ||
| 020 | _a9789811382734 | ||
| 024 | 7 |
_a10.1007/978-981-13-8273-4 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC681 _b2019 EB |
|
| 245 | 0 | 0 |
_aOxidative Stress in Heart Diseases _cedited by Sajal Chakraborti, Naranjan S Dhalla, Nirmal K Ganguly, Madhu Dikshit. |
| 250 | _aFirst edition | ||
| 264 | 1 |
_aSingapore _bSpringer International Publishing _c2019 |
|
| 300 |
_a1 recurso en línea (XIII, 596 páginas) _b66 ilustraciones |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 505 | 0 | _aI. Role of Oxidative Stress in Heart Diseases -- 1. J.L Johnson. Laboratory of cardiovascular pathology, School of Clinical Sciences, University of Bristol, Bristol. UK -- 2. M.A.Srivastava, Department of Physiology, McGill University, Canada -- 3. P. Balakumar. Pharmacology Unit, AIMST University, Semeling 08100 Bedong, Kedah Darul Aman, Malaysia -- 4. K. B Pasumarthi. Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada -- 5. B. Turan. Department of Biophysics, Ankara University, Faculty of Medicine, Ankara,Turkey -- 6. Z. Xie. Marshall Institute of Interdisciplinary Research, Marshall University, Huntington,WV, USA -- 7. T. L. Haas. Angiogenesis Research Group, School of Health Sciences, York University,Toronto, Canada -- 8. A. Kukol. School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK -- 9. N.S.Dhalla, Cardiovascular Research Institute, University of Manitoba, Winnipeg, Canada -- 10. A.K.Srivastava. Cell Signalling laboratory, McGill University, Canada -- 11. S.Chakraborti, University of Kalyani, Kalyani 741235, West Bengal, India -- 12. S.Goswami, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India -- 13. C.C.Kartha, Rajiv Gandhi Institute of Biotechnology, Thiruvanatapuram, India -- 14. S.K.Malick, Department of Pharmacology. AIIMS, New Delhi, India -- 15. S.Chatterjee, Anna University, Chennai, India -- 16. N.Mahapatra, IIT-Madras, Chennai, India -- 17. R. Bhunya, Department of Biochemistry and Biophysicvs, University of kalyani, West Bengal, India -- 18. S.Nandi, North Est Hill University, Meghalaya, India -- 19. N.K.Ganguly, Sir gangaram Hospital, New Delhi -- 20. M.Dixit, CSIR-CDR, -Lucknow, India -- 21. A.D.Abell, University of Adelaide, Australia -- 22. Chava Kimchi Sarfaty, Centre for Biologics Evaluation and Research, Foodand Drug Administration, Bethesda, Maryland, USA -- 23. B. Furhman, Technion Faculty of Medicine and Ramban Medical Center, Hiafa, Israel -- 24. R.F.Gerlach, Department of Physiology, University of Sao Paulo, Brazil -- 25.T.L.Haas, School of Kinesiology and Health Sciences, York University, Toronto, Canada -- 26. B. Mittal, Department of Genetics. Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttap Pradesh, India -- 27. Richard Schulz, Department of Pedfiatrics, University of Alberta, Canada -- 28. Bodh J Jugdutt, Mackenzie Haeth Sciences Centre, Division of Cardiology, University of Alberta, Canada -- 29. Vibha Rani, Jaypee Institute of Information Technology, Noida, Uttar Pradesh, India -- 34. Veena Dhawan, Department of Experimental Medicine and Biotechnology,PGIMER,Chandigarh, India -- 30. Surekha Rani, Department of Genetics, Osmania University, Hyderabad, Telengana State, India. | |
| 520 | 3 | _aThis book bridges the gap between fundamental and translational research in the area of heart disease. It describes a multidisciplinary approach, and demonstrates biochemical mechanisms associated with dysregulation of redox signaling, which leads heart disease. Presenting recent studies on improved forms of ROS scavenging enzymes; specific inhibitors for different ROS generating enzymes; and oxidant induced signaling pathways and their antagonists that allow subtle modulation of redox signaling, it also discusses the spatial and temporal aspects of oxidative stress in the cardiovascular system, which are of vital importance in developing better strategies for treating heart disease. Each chapter offers researchers valuable insights into identifying targets for drug development for different types of heart disease. | |
| 988 | _aPrimersemestre_2020_BiomedLife | ||
| 650 | 7 |
_2embne _aCorazón _xEnfermedades _9169667 |
|
| 700 | 1 |
_aChakraborti, Sajal _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _984935 |
|
| 700 | 1 |
_aDhalla, Naranjan S. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _984616 |
|
| 700 |
_aGanguly, Nirmal Kumar _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _985912 |
||
| 700 | 1 |
_aDikshit, Madhu _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811382727 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811382741 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811382758 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-8273-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE _n0 |
||
| 998 |
_b03/2020 _dz _ek _zSI |
||